Diagnósticos da América S.A. (BOVESPA:DASA3) agreed to acquire Laboratório PATOLOGIA CLÍNICA DR. GERALDO LUSTOSA CABRAL LTDA in June 2022. Lustosa has BRL 49.6 million in revenue in 2021, The conclusion of this transaction is subject to compliance with certain condition precedents, including approval from the Brazilian Antitrust Authority (CADE).